Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in Situ
1976; Lippincott Williams & Wilkins; Volume: 116; Issue: 5 Linguagem: Inglês
10.1016/s0022-5347(17)58916-8
ISSN1527-3792
AutoresAlex F. Althausen, George R. Prout, James Daly,
Tópico(s)Urological Disorders and Treatments
ResumoNo AccessJournal of Urology1 Nov 1976Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in Situ Alex F. Althausen, George R. Prout, and James J. Daly Alex F. AlthausenAlex F. Althausen , George R. ProutGeorge R. Prout , and James J. DalyJames J. Daly View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)58916-8AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail We evaluated 129 patients with low grade, low stage transitional cell carcinoma of the bladder with a minimum followup of 5 years. In addition to the phenomena recognized as indicators of a serious clinical problem (grade greater than I, rapid recurrence, multiple tumors and lamina propria invasion) the identification of carcinoma in situ and/or atypia in normal, incidentally resected mucosa adjacent to the tumor was found to be a positive predictor for subsequent muscle invasion. Ten of 12 patients with carcinoma in situ and 9 of 25 patients with atypia were among 39 who experienced invasion. © 1976 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByChade D, Shariat S, Godoy G, Savage C, Cronin A, Bochner B, Donat S, Herr H and Dalbagni G (2018) Clinical Outcomes of Primary Bladder Carcinoma In Situ in a Contemporary SeriesJournal of Urology, VOL. 184, NO. 1, (74-80), Online publication date: 1-Jul-2010.Chade D, Shariat S, Adamy A, Bochner B, Donat S, Herr H and Dalbagni G (2018) Clinical Outcome of Primary Versus Secondary Bladder Carcinoma In SituJournal of Urology, VOL. 184, NO. 2, (464-469), Online publication date: 1-Aug-2010.Chrouser K, Leibovich B, Bergstralh E, Zincke H and Blute M (2018) Bladder Cancer Risk Following Primary and Adjuvant External Beam Radiation for Prostate CancerJournal of Urology, VOL. 179, NO. 5S, (S7-S11), Online publication date: 1-May-2008.Fradet Y, Grossman H, Gomella L, Lerner S, Cookson M, Albala D and Droller M (2018) A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter StudyJournal of Urology, VOL. 178, NO. 1, (68-73), Online publication date: 1-Jul-2007.CHROUSER K, LEIBOVICH B, BERGSTRALH E, ZINCKE H and BLUTE M (2018) BLADDER CANCER RISK FOLLOWING PRIMARY AND ADJUVANT EXTERNAL BEAM RADIATION FOR PROSTATE CANCERJournal of Urology, VOL. 174, NO. 1, (107-110), Online publication date: 1-Jul-2005.KWAK C, KU J, PARK J, LEE E, LEE S and LEE C (2018) Initial Tumor Stage and Grade as a Predictive Factor for Recurrence in Patients With Stage T1 Grade 3 Bladder CancerJournal of Urology, VOL. 171, NO. 1, (149-152), Online publication date: 1-Jan-2004.HASSAN J, COOKSON M, SMITH J, JOHNSON D and CHANG S (2018) OUTCOMES IN PATIENTS WITH PATHOLOGICAL CARCINOMA IN SITU ONLY DISEASE AT RADICAL CYSTECTOMYJournal of Urology, VOL. 172, NO. 3, (882-884), Online publication date: 1-Sep-2004.LEVI A, POTTER S, SCHOENBERG M and EPSTEIN J (2018) CLINICAL SIGNIFICANCE OF DENUDED UROTHELIUM IN BLADDER BIOPSYJournal of Urology, VOL. 166, NO. 2, (457-460), Online publication date: 1-Aug-2001.KIM J and STEINBERG G (2018) THE LIMITS OF BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDERJournal of Urology, VOL. 165, NO. 3, (745-756), Online publication date: 1-Mar-2001.QURESHI K, NAGUIB R, HAMDY F, NEAL D and MELLON J (2018) NEURAL NETWORK ANALYSIS OF CLINICOPATHOLOGICAL AND MOLECULAR MARKERS IN BLADDER CANCERJournal of Urology, VOL. 163, NO. 2, (630-633), Online publication date: 1-Feb-2000.HERR H (2018) TUMOR PROGRESSION AND SURVIVAL OF PATIENTS WITH HIGH GRADE, NONINVASIVE PAPILLARY (TaG3) BLADDER TUMORS: 15-YEAR OUTCOMEJournal of Urology, VOL. 163, NO. 1, (60-62), Online publication date: 1-Jan-2000.Stampfer D, Carpinito G, Rodriquez-Villanueva J, Willsey L, Dinney C, Grossman H, Fritsche H and McDougal W (2018) EVALUATION OF NMP22 IN THE DETECTION OF TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, VOL. 159, NO. 2, (394-398), Online publication date: 1-Feb-1998.Sharkey F and Sarosdy M (2018) The Significance of Central Pathology Review in Clinical Studies of Transitional Cell Carcinoma in SituJournal of Urology, VOL. 157, NO. 1, (68-71), Online publication date: 1-Jan-1997.Lee E, Schwaibold H, Fradet Y, Huland E and Huland H (2018) Tumor-Associated Antigens in Normal Mucosa of Patients With Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 157, NO. 3, (1070-1073), Online publication date: 1-Mar-1997.Ovesen H, Horn T and Steven K (2018) Long-Term Efficacy of Intravesical Bacillus Calmette-Guerin for Carcinoma in Situ: Relationship of Progression to Histological Response and p53 Nuclear AccumulationJournal of Urology, VOL. 157, NO. 5, (1655-1659), Online publication date: 1-May-1997.Tanaka Y, Kawamata H, Fujimoto K and Oyasu R (2018) Angiogenesis Inhibitor TNP-470 Suppresses Tumorigenesis In Rat Urinary BladderJournal of Urology, VOL. 157, NO. 2, (683-688), Online publication date: 1-Feb-1997.Ozdemir E, Kakehi Y, Okuno H, Habuchi T, Okada Y and Yoshida O (2018) Strong Correlation of Basement Membrane Degradation With P53 Inactivation and/or MDM2 Overexpression in Superficial Urothelial CarcinomasJournal of Urology, VOL. 158, NO. 1, (206-211), Online publication date: 1-Jul-1997.Koenig F, McGovern F, Althausen A, Deutsch T and Schomacker K (2018) Laser Induced Autofluorescence Diagnosis of Bladder CancerJournal of Urology, VOL. 156, NO. 5, (1597-1601), Online publication date: 1-Nov-1996.Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F and Hofstetter A (2018) Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin FluorescenceJournal of Urology, VOL. 155, NO. 1, (105-110), Online publication date: 1-Jan-1996.Mellon K, Wright C, Kelly P, Horne C and Neal D (2018) Original Articles: Bladder Cancer: Long-Term Outcome Related to Epidermal Growth Factor Receptor Status in Bladder CancerJournal of Urology, VOL. 153, NO. 3S, (919-925), Online publication date: 1-Mar-1995.Dinney C, Ramirez E, Swanson D, Ro J, Babaian R and von Eschenbach A (2018) Original Articles: Bladder Cancer: Management of Transitional Cell Carcinoma Involving Von Brunn's NestsJournal of Urology, VOL. 153, NO. 3S, (944-949), Online publication date: 1-Mar-1995.Hudson M and Herr H (2018) Carcinoma in Situ of the BladderJournal of Urology, VOL. 153, NO. 3, (564-572), Online publication date: 1-Mar-1995.Amling C, Thrasher J, Frazier H, Dodge R, Robertson J and Paulson D (2018) Radical Cystectomy for Stages TA, TIS and T1 Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 151, NO. 1, (31-35), Online publication date: 1-Jan-1994.Heinzer H, Huland E, Mönk M and Huland H (2018) Distribution of 486P 3/12 Antigen, Abo(H) Blood Group Antigen and T Antigen in Cystectomy Specimens from Patients with Stage T2 Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 148, NO. 3 Part 1, (802-805), Online publication date: 1-Sep-1992.Prout G, Barton B, Griffin P and Friedell G (2018) Treated History of Noninvasive Grade 1 Transitional Cell CarcinomaJournal of Urology, VOL. 148, NO. 5 Part 1, (1413-1419), Online publication date: 1-Nov-1992.Norming U, Tribukait B, Nyman C, Nilsson B and Wang N (2018) Prognostic Significance of Mucosal Aneuploidy in Stage Ta/T1 Grade 3 Carcinoma of the BladderJournal of Urology, VOL. 148, NO. 5 Part 1, (1420-1426), Online publication date: 1-Nov-1992.Tobisu K, Tanaka Y, Mizutani T and Kakizoe T (2018) Transitional Cell Carcinoma of the Urethra in Men Following Cystectomy for Bladder Cancer: Multivariate Analysis for Risk FactorsJournal of Urology, VOL. 146, NO. 6, (1551-1553), Online publication date: 1-Dec-1991.Schmittgen T, Au J, Wientjes M, Badalament R and Drago J (2018) Cultured Human Bladder Tumors for Pharmacodynamic StudiesJournal of Urology, VOL. 145, NO. 1, (203-207), Online publication date: 1-Jan-1991.Levi D'Ancona C, Rodrigues Netto N, Almeida Claro J and Ikari O (2018) Oral or Intravesical Bacillus Calmette-Guerin Immunoprophylaxis in Bladder CarcinomaJournal of Urology, VOL. 145, NO. 3, (498-501), Online publication date: 1-Mar-1991. (2018) Reply by AuthorsJournal of Urology, VOL. 146, NO. 6, (1513-1513), Online publication date: 1-Dec-1991.Catalona W (2018) Editorial CommentJournal of Urology, VOL. 145, NO. 1, (43-44), Online publication date: 1-Jan-1991.Huland E, Huland H and Schneider A (2018) Quantitative Immunocytology in the Management of Patients with Superficial bladder Carcinoma. I. A Marker to Identify Patients Who do not Require ProphylaxisJournal of Urology, VOL. 144, NO. 3, (637-639), Online publication date: 1-Sep-1990.Bruce Malkowicz S, Nichols P, Lieskovsky G, Boyd S, Huffman J and Skinner D (2018) The Role of Radical Cystectomy in the Management of High Grade Superficial Bladder Cancer (PA, P1PIS and P2)Journal of Urology, VOL. 144, NO. 3, (641-645), Online publication date: 1-Sep-1990.Martínez Piñeiro J, León J, Martínez Piñeiro L, Fiter L, Mosteiro J, Navarro J, García Matres M and Cárcamo P (2018) Bacillus Calmette-Guerin Versus Doxorubicin Versus Thiotepa: A Randomized Prospective Study in 202 Patients with Superficial Bladder CancerJournal of Urology, VOL. 143, NO. 3, (502-506), Online publication date: 1-Mar-1990.Droller M (2018) Editorial CommentsJournal of Urology, VOL. 144, NO. 3, (639-639), Online publication date: 1-Sep-1990.Oyasu R (2018) Editorial CommentsJournal of Urology, VOL. 144, NO. 3, (639-640), Online publication date: 1-Sep-1990.Parmar M, Freedman L, Hargreave T and Tolley D (2018) Prognostic Factors for Recurrence and Followup Policies in the Treatment of Superficial Bladder Cancer: Report from the British Medical Research Council Subgroup On Superficial Bladder Cancer (Urological Cancer Working Party)Journal of Urology, VOL. 142, NO. 2 Part 1, (284-288), Online publication date: 1-Aug-1989.Herr H, Badalament R, Amato D, Laudone V, Fair W and Whitmore W (2018) Superficial Bladder Cancer Treated with Bacillus Calmette-Guerin: A Multivariate Analysis of Factors Affecting Tumor ProgressionJournal of Urology, VOL. 141, NO. 1, (22-28), Online publication date: 1-Jan-1989.deVere White R, Deitch A, West B and Fitzpatrick J (2018) The Predictive Value of Flow Cytometric Information in the Clinical Management of Stage O (Ta) Bladder CancerJournal of Urology, VOL. 139, NO. 2, (279-282), Online publication date: 1-Feb-1988.Rübben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W and Giani G (2018) Natural History and Treatment of Low and High Risk Superficial Bladder TumorsJournal of Urology, VOL. 139, NO. 2, (283-285), Online publication date: 1-Feb-1988.Orihuela E and Shahon R (2018) Influence of Blood Group Type on the Natural History of Superficial Bladder CancerJournal of Urology, VOL. 138, NO. 4 Part 1, (758-759), Online publication date: 1-Oct-1987.Badalament R, Gay H, Cibas E, Herr H, Whitmore W, Fair W and Melamed M (2018) Monitoring Endoscopic Treatment of Superficial Bladder Carcinoma by Postoperative Urinary CytologyJournal of Urology, VOL. 138, NO. 4 Part 1, (760-762), Online publication date: 1-Oct-1987.Badalament R, Gay H, Cibas E, Herr H, Whitmore W, Fair W and Melamed M (2018) Monitoring Intravesical Bacillus Calmette-Guerin Treatment of Superficial Bladder Carcinoma by Postoperative Urinary CytologyJournal of Urology, VOL. 138, NO. 4 Part 1, (763-765), Online publication date: 1-Oct-1987.Prout G, Griffin P and Daly J (2018) The Outcome of Conservative Treatment of Carcinoma in Situ of the BladderJournal of Urology, VOL. 138, NO. 4 Part 1, (766-770), Online publication date: 1-Oct-1987.Herr H, Laudone V and Whitmore W (2018) An Overview of Intravesical Therapy for Superficial Bladder TumorsJournal of Urology, VOL. 138, NO. 6, (1363-1368), Online publication date: 1-Dec-1987.Catalona W, Hudson M, Gillen D, Andriole G and Ratliff T (2018) Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, VOL. 137, NO. 2, (220-224), Online publication date: 1-Feb-1987.Herr H, Pinsky C, Whitmore W, Sogani P, Oettgen H and Melamed M (2018) Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, VOL. 135, NO. 2, (265-267), Online publication date: 1-Feb-1986.Kakizoe T, Matumoto K, Nishio Y, Ohtani M and Kishi K (2018) Significance of Carcinoma in Situ and Dysplasia in Association with Bladder CancerJournal of Urology, VOL. 133, NO. 3, (395-398), Online publication date: 1-Mar-1985.deKernion J, Huang M, Lindner A, Smith R and Kaufman J (2018) The Management of Superficial Bladder Tumors and Carcinoma in situ with Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. 133, NO. 4, (598-600), Online publication date: 1-Apr-1985.Jakse G, Hofstädter F and Marberger H (2018) Topical Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the Bladder: A FollowupJournal of Urology, VOL. 131, NO. 1, (41-42), Online publication date: 1-Jan-1984.Soloway M (2018) Editorial CommentJournal of Urology, VOL. 131, NO. 1, (42-42), Online publication date: 1-Jan-1984. (2018) Reply by AuthorsJournal of Urology, VOL. 131, NO. 1, (42-42), Online publication date: 1-Jan-1984.Kakizoe T, Matsumoto K, Nishio Y and Kishi K (2018) Analysis of 90 Step-Sectioned Cystectomised Specimens of Bladder CancerJournal of Urology, VOL. 131, NO. 3, (467-472), Online publication date: 1-Mar-1984.Wajsman Z, McGill W, Englander L, Huben R and Pontes J (2018) Severely Contracted Bladder Following Intravesical Mitomycin C TherapyJournal of Urology, VOL. 130, NO. 2, (340-341), Online publication date: 1-Aug-1983.Soloway M (2018) Editorial CommentJournal of Urology, VOL. 130, NO. 2, (341-341), Online publication date: 1-Aug-1983.Walzer Y and Soloway M (2018) Should the Followup of Patients with Bladder Cancer Include Routine Excretory Urography?Journal of Urology, VOL. 130, NO. 4, (672-673), Online publication date: 1-Oct-1983.Grabstald H (2018) Editorial CommentJournal of Urology, VOL. 130, NO. 4, (673-673), Online publication date: 1-Oct-1983. (2018) Reply by AuthorsJournal of Urology, VOL. 130, NO. 4, (673-673), Online publication date: 1-Oct-1983.Nissenkorn I, Slutzker D, Schujman E and Servadio C (2018) The Influence of Lower Urinary Tract Infection on the Recurrence Rate of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 130, NO. 4, (674-676), Online publication date: 1-Oct-1983.Droller M (2018) Editorial CommentJournal of Urology, VOL. 130, NO. 4, (676-676), Online publication date: 1-Oct-1983.Farsund T, Laerum O and Høstmark J (2018) Ploidy Disturbance of Normal-Appearing Bladder Mucosa in Patients with Urothelial Cancer: Relationship to MorphologyJournal of Urology, VOL. 130, NO. 6, (1076-1082), Online publication date: 1-Dec-1983.Heney N, Ahmed S, Flanagan M, Frable W, Corder M, Hafermann M and Hawkins I (2018) Superficial Bladder Cancer: Progression and RecurrenceJournal of Urology, VOL. 130, NO. 6, (1083-1086), Online publication date: 1-Dec-1983.Utz D (2018) Editorial CommentsJournal of Urology, VOL. 130, NO. 6, (1086-1086), Online publication date: 1-Dec-1983.Droller M (2018) Editorial CommentsJournal of Urology, VOL. 130, NO. 6, (1086-1086), Online publication date: 1-Dec-1983.Lundbeck F, Mogensen P and Jeppesen N (2018) Intravesical Therapy of Noninvasive Bladder Tumors (Stage Ta) with Doxorubicin and UrokinaseJournal of Urology, VOL. 130, NO. 6, (1087-1089), Online publication date: 1-Dec-1983.Droller M (2018) The Controversial Role of Radiation Therapy as Adjunctive Treatment of Bladder CancerJournal of Urology, VOL. 129, NO. 5, (897-903), Online publication date: 1-May-1983.Schade R and Swinney J (2018) The Association of Urothelial Abnormalities With Neoplasia: A 10-Year FollowupJournal of Urology, VOL. 129, NO. 6, (1125-1126), Online publication date: 1-Jun-1983.Soloway M (2018) Editorial CommentJournal of Urology, VOL. 129, NO. 6, (1126-1126), Online publication date: 1-Jun-1983. (2018) Reply by AuthorsJournal of Urology, VOL. 129, NO. 6, (1126-1126), Online publication date: 1-Jun-1983.Kaye K and Lange P (2018) Mode of Presentation of Invasive Bladder Cancer: Reassessment of the ProblemJournal of Urology, VOL. 128, NO. 1, (31-33), Online publication date: 1-Jul-1982.McCarron J, Chasko S and Gray G (2018) Systematic Mapping of Nephroureterectomy Specimens Removed for Urothelial Cancer: Pathological Findings and Clinical CorrelationsJournal of Urology, VOL. 128, NO. 2, (243-246), Online publication date: 1-Aug-1982.Marshall F (2018) Editorial CommentJournal of Urology, VOL. 128, NO. 2, (246-246), Online publication date: 1-Aug-1982.Hammou J, Fella C, Vacant J, Maiolini R and Masseyeff R (2018) Improvement of the Demonstration of A, B, H Surface Antigens in Bladder Tumors by a Simple Immunofluorescence TechniqueJournal of Urology, VOL. 128, NO. 6, (1183-1187), Online publication date: 1-Dec-1982.Murphy W and Soloway M (2018) Urothelial DysplasiaJournal of Urology, VOL. 127, NO. 5, (849-854), Online publication date: 1-May-1982.Stein B, Reyes J, Petersen R, McNellis D and Kendall A (2018) Specific Red Cell Adherence: Immunologic Evaluation of Random Mucosal biopsies In Carcinoma of the BladderJournal of Urology, VOL. 126, NO. 1, (37-40), Online publication date: 1-Jul-1981.Soloway M (2018) Editorial CommentJournal of Urology, VOL. 126, NO. 1, (40-40), Online publication date: 1-Jul-1981.Heney N, Nocks B, Daly J, Blitzer P and Parkhurst E (2018) Prognostic Factors in Carcinoma of the UreterJournal of Urology, VOL. 125, NO. 5, (632-636), Online publication date: 1-May-1981.Kakizoe T, Fujita J, Murase T, Matsumoto K and Kishi K (2018) Transitional Cell Carcinoma of the Bladder in Patients with Renal Pelvic and Ureteral CancerJournal of Urology, VOL. 124, NO. 1, (17-19), Online publication date: 1-Jul-1980.Droller M (2018) Editorial CommentJournal of Urology, VOL. 124, NO. 1, (19-19), Online publication date: 1-Jul-1980.Catalona W (2018) Bladder CarcinomaJournal of Urology, VOL. 123, NO. 1, (35-36), Online publication date: 1-Jan-1980.Nocks B, Nieh P and Prout G (2018) A Longitudinal Study of Patients with Superficial Bladder Carcinoma Successfully Treated with Weekly Intravesical Thio-TEPAJournal of Urology, VOL. 122, NO. 1, (27-29), Online publication date: 1-Jul-1979.Kramer S, Bredael J, Croker B, Paulson D and Glenn J (2018) Primary Non-Urachal Adenocarcinoma of the BladderJournal of Urology, VOL. 121, NO. 3, (278-281), Online publication date: 1-Mar-1979.Soloway M, Murphy W, Rao M and Cox C (2018) Serial Multiple-Site Biopsies in Patients with Bladder CancerJournal of Urology, VOL. 120, NO. 1, (57-59), Online publication date: 1-Jul-1978.Eggleston J (2018) Editorial CommentJournal of Urology, VOL. 120, NO. 1, (59-59), Online publication date: 1-Jul-1978.Heney N, Daly J, Prout G, Nieh P, Heaney J and Trebeck N (2018) Biopsy of Apparently Normal Urothelium in Patients with Bladder CarcinomaJournal of Urology, VOL. 120, NO. 5, (559-560), Online publication date: 1-Nov-1978.Gilbert H, Logan J, Kagan A, Friedman H, Cove J, Fox M, Muldoon T, Lonni Y, Rowe J, Cooper J, Nussbaum H, Chan P, Rao A and Starr A (2018) The Natural History of Papillary Transitional Cell Carcinoma of the Bladder and its Treatment in an Unselected Population on the Basis of Histologic GradingJournal of Urology, VOL. 119, NO. 4, (488-492), Online publication date: 1-Apr-1978.Murphy W (2018) Falsely Positive Urinary Cytology: Pathologist's Error or Preclinical Cancer?Journal of Urology, VOL. 118, NO. 5, (811-813), Online publication date: 1-Nov-1977. Volume 116Issue 5November 1976Page: 575-580 Advertisement Copyright & Permissions© 1976 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Alex F. Althausen More articles by this author George R. Prout More articles by this author James J. Daly More articles by this author Expand All Advertisement PDF DownloadLoading ...
Referência(s)